NOXXON Announces First Brain Cancer Patient Reaches 10 Weeks of Treatment With NOX-A12 Plus Radiotherapy
Data Safety Monitoring Board confirms safety and validates the recruitment of next patients BERLIN–(BUSINESS WIRE)–Regulatory News: NOXXON Pharma N.V. (Paris:ALNOX)…